Abstract:Abstract Background Before the deposition of amyloid-beta plaques and the onset of learning memory deficits, patients with Alzheimer’s disease (AD) experience olfactory dysfunction, typified by a reduced ability to detect, discriminate, and identify odors. Rodent models of AD, such as the Tg2576 and APP/PS1 mice, also display impaired olfaction, accompanied by aberrant in vivo or in vitro gamma rhythms in the olfactory pathway. However, the mechanistic relationships between the electrophysiological, biochemical and behavioral phenomena remain unclear. Methods To address the above issues in AD models, we conducted in vivo measurement of local field potential (LFP) with a combination of in vitro electro-olfactogram (EOG), whole-cell patch and field recordings to evaluate oscillatory and synaptic function and pharmacological regulation in the olfactory pathway, particularly in the olfactory bulb (OB). Levels of protein involved in excitation and inhibition of the OB were investigated by western blotting and fluorescence staining, while behavioral studies assessed olfaction and memory function. Results LFP measurements demonstrated an increase in gamma oscillations in the OB accompanied by altered olfactory behavior in both APP/PS1 and 3xTg mice at 3–5 months old, i.e. an age before the onset of plaque formation. Fewer olfactory sensory neurons (OSNs) and a reduced EOG contributed to a decrease in the excitatory responses of M/T cells, suggesting a decreased ability of M/T cells to trigger interneuron GABA release indicated by altered paired-pulse ratio (PPR), a presynaptic parameter. Postsynaptically, there was a compensatory increase in levels of GABA A R α1 and β3 subunits and subsequent higher amplitude of inhibitory responses. Strikingly, the GABA uptake inhibitor tiagabine (TGB) ameliorated abnormal gamma oscillations and levels of GABA A R subunits, suggesting a potential therapeutic strategy for early AD symptoms. These findings reveal increased gamma oscillations in the OB as a core indicator prior to onset of AD and uncover mechanisms underlying aberrant gamma activity in the OB. Conclusions This study suggests that the concomitant dysfunction of both olfactory behavior and gamma oscillations have important implications for early AD diagnosis: in particular, awareness of aberrant GABAergic signaling mechanisms might both aid diagnosis and suggest therapeutic strategies for olfactory damage in AD.

The Mechanisms Underlying Olfactory Deficits in Apolipoprotein E–deficient Mice: Focus on Olfactory Epithelium and Olfactory Bulb

Enhancing GABAergic signaling ameliorates aberrant gamma oscillations of olfactory bulb in AD mouse models

Pathological features and molecular signatures of early olfactory dysfunction in 3xTg‐AD model mice

ErbB4 Deficiency Exacerbates Olfactory Dysfunction in an Early-Stage Alzheimer’s Disease Mouse Model

Impairment of Dendrodendritic Inhibition in the Olfactory Bulb of APP/PS1 Mice

Altered Odor-Evoked Electrophysiological Responses in the Anterior Piriform Cortex of Conscious APP/PS1 Mice

Apo E4 Alleles and Impaired Olfaction as Predictors of Alzheimer’s Disease

DNA polymerase β decrement triggers death of olfactory bulb cells and impairs olfaction in a mouse model of Alzheimer's disease

Olfactory deficit: a potential functional marker across the Alzheimer's disease continuum

GABAA Receptor Agonist Muscimol Rescues Inhibitory Microcircuit Defects in the Olfactory Bulb and Improves Olfactory Function in APP/PS1 Transgenic Mice

A Potential Biomarker of Preclinical Alzheimer’s Disease: the Olfactory Dysfunction and Its Pathogenesis-Based Neural Circuitry Impairments

The Decreased Astrocyte-Microglia Interaction Reflects the Early Characteristics of Alzheimer’s Disease

Age-Related Changes in the Behavior of Apolipoprotein E Knockout Mice

Olfactory Deficits Induce Neurofilament Hyperphosphorylation

Lack of Ameliorative Effect of Chronic Oral Nicotine on Olfactory Dysfunction in Young Adult Presenilin-1/2 Double Knockout Mice of a Dementia Model

Amelioration of Olfactory Dysfunction in a Mouse Model of Parkinson’s Disease Via Enhancing GABAergic Signaling

Single‐nuclei Spatiotemporal Transcriptomics Reveal an APOE4‐associated Specific Oligodendrocyte Signature

Behavioural, physiological and morphological analysis of a line of apolipoprotein E knockout mouse.

Apolipoprotein E knockout may affect cognitive function in D-galactose-induced aging mice through the gut microbiota–brain axis

Specific neurochemical derangements of brain projecting neurons in apolipoprotein E-deficient mice

Expression Profiling of Cytokine, Cholinergic Markers, and Amyloid-β Deposition in the APPSWE/PS1dE9 Mouse Model of Alzheimer's Disease Pathology.